<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04579146</url>
  </required_header>
  <id_info>
    <org_study_id>2019-A00219-48</org_study_id>
    <nct_id>NCT04579146</nct_id>
  </id_info>
  <brief_title>Coronary Artery Disease (CAD) in Patients HIV-infected</brief_title>
  <acronym>CoroVIH</acronym>
  <official_title>ROLE OF IMMUNE ACTIVATION PROFILES IN CORONARY ATHEROTHROMBOSIS IN PATIENTS HIV-1-INFECTED ON EFFECTIVE ANTIRETROVIRAL THERAPY</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hôpital Européen Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hôpital Européen Marseille</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      HIV-infected patients with intermediate-high risk have a high prevalence of CAD and a&#xD;
      substantial proportion of obstructive CAD. Degree of stenosis is associated with&#xD;
      immunoactivation (lymphocyte and monocyte) and microbial translocation&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 7, 2020</start_date>
  <completion_date type="Anticipated">October 2023</completion_date>
  <primary_completion_date type="Anticipated">October 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>correlation between a particular profile of immune activation in patients HIV under treatment presenting cardiovascular risk factors and the presence of coronary atheromatous plaques</measure>
    <time_frame>24 months</time_frame>
    <description>Assessment of the prevalence of obstructive coronary artery disease in patients infected with HIV and asymptomatic with a 64-slice CT coronary angiography.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Identify the bacterial populations constituting the intestinal microbiota in patients infected with HIV and look for a microbiotic signature in patients with subclinical atherothrombosis.</measure>
    <time_frame>24 months</time_frame>
    <description>microbial translocation (16S DNA)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>HIV Infections</condition>
  <arm_group>
    <arm_group_label>HIV-1 patients and treated effectively for more than 12 months</arm_group_label>
    <description>X-ray examination with contrast by a 64-slice CT coronary angiography.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>coronary computed tomographic angiographic (CCTA)</intervention_name>
    <description>x-ray examination with contrast by a 64-slice CT coronary angiography.</description>
    <arm_group_label>HIV-1 patients and treated effectively for more than 12 months</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient VIH-1&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        HIV-infected patients &gt;= 45 years with 2 or more CV risk factors currently on ART HIV-RNA &lt;&#xD;
        50 copies &gt;= 12 months (one blip allowed) Asymptomatic regarding cardiac symptoms (chest&#xD;
        pain, syncope, dyspnea) Stable ART for more than 6 months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Sign of coronary pathology (chest pain, syncope, dyspnea).&#xD;
&#xD;
          -  ATCD of allergy to IV contrast agents&#xD;
&#xD;
          -  Chronic inflammatory disease other than HIV&#xD;
&#xD;
          -  Subject to a measure for the protection of justice&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>BENNANI</name>
      <address>
        <city>Marseille</city>
        <zip>13003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Myriam BENNANI</last_name>
      <phone>0413428351</phone>
      <email>m.bennani@hopital-europeen.fr</email>
    </contact>
    <investigator>
      <last_name>Christina PSOMAS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 24, 2020</study_first_submitted>
  <study_first_submitted_qc>October 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 8, 2020</study_first_posted>
  <last_update_submitted>October 1, 2020</last_update_submitted>
  <last_update_submitted_qc>October 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

